At Synamics Therapeutics, we are guided by a dedicated team of seasoned leaders, driven by a commitment to put patients at the heart of everything we do. Our leadership roster is composed of experienced entrepreneurs, industry veterans, and globally recognized scientists. Our focus is crystal clear: to revolutionize drug discovery through cutting-edge computational and AI methods. With a patient-centric approach as our driving force, we channel all our efforts into delivering breakthroughs that can transform lives, without delay.
Synamics Founders
Board of Advisors
Bryn-Williams Jones, B.Sc (Hons)
CEO at The Open PHACTS Foundation,
Former SVP of Drug Discovery at BenevolentAI
Lydie Roux, MBA
Jes Broeng, PhD
VP Business Operations GSK France, Former Executive at Novo Nordisk and MSD
Professor & Director, DTU Entrepreneurship, Programme Director for Open Entrepreneurship, Technical University of Denmark